How could we forget the SARS-CoV-2 pandemic, right? It’s now part of our history, a story to pass on to the next generation. There are hundreds of related SARS-CoV strains known to infect different ...

This post continues from my previous article, which discusses the clinical differences between COVID-19 and the seasonal flu. These two diseases progress so differently because the viruses that cause ...

A team has found two antibodies that can work together to neutralize the virus that causes COVID-19 in all its current known variations in a laboratory environment. More research is needed, but the ...

Source: Movie poster (1950) for The Thing From Another World Some of us have grown up watching scary movies—The Thing From Another World; The Blob, with Steve McQueen; and more recently, Outbreak, a ...

Neutralizing antibodies that merely block receptor binding are losing ground against heavily mutated SARS-CoV-2 Omicron sub-variants. A new approach now exploits a llama-derived nanobody—VHH21—that ...

SARS-CoV-2 has rampantly spread around the globe and continues to cause unprecedented loss through ongoing waves of (re)infection. Increasing our understanding of the protection against infection with ...

WHO said the decision builds on earlier emergency approvals and reflects the continued need for affordable, fast COVID-19 testing even after the pandemic’s emergency phase.

A previously overlooked type of immune cell allows SARS-CoV-2 to proliferate, scientists have found. The discovery has important implications for preventing severe COVID-19. The lung-cell type that's ...

A visual representation of the novel in silico methodology used in the study: prediction of protein structure, molecular docking simulations, and statistical analysis of computational metrics. New ...

Research led by the Wuhan Institute of Virology has identified a distinct bat virus lineage capable of infecting human cells ...